However, their popularity has surged beyond traditional endocrinology clinics
In theory, there are millions of microbe species that can be engineered to synthesize peptides
The company received five approvals in Europe including Enhertu (trastuzumab-deruxtecan) for gastric cancer and breast cancer, Imfinzi (durvalumab) for biliary tract cancer and Forxiga (dapagliflozin) for heart failure
Market Size & Growth Forecasts The global GLP-1 analogues market is estimated at $66.48 billion in 2025, projected to skyrocket to $879.9 billion by 2034, representing an impressive CAGR of ~33.2% Another source estimates the broader GLP-1 market at $47.74 billion in 2024, with a more conservative CAGR of 10.9% from 20252034
Structure of Arg34Lys26-(N-epsilon;-(gamma;-Glu(N-alpha;-hexadecanoyl)))-GLP-1(7-37) Liraglutide peptide shares about 97% sequence identity with human GLP-1 but contains specific modifications that improve its pharmacological stability and duration
I was never a stick, she tells me
